Article Details

FDA accepts supplemental Biologics Licence Application for Roche's Polivy combination

Retrieved on: 2022-08-16 06:04:51

Tags for this article:

Click the tags to see associated articles and topics

FDA accepts supplemental Biologics Licence Application for Roche's Polivy combination. View article details on hiswai:

Excerpt

The US Food and Drug Administration (FDA) has accepted the Roche's supplemental Biologics License Application (sBLA) for Polivy (polatuzumab ...

Article found on: www.expresspharma.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up